Wise LA, Wesselink AK, Hatch EE, Rothman KJ, Mikkelsen EM, Sorensen HT, Mahalingaiah S. Marijuana use and fecundability in a North American preconception cohort study. J Epidemiol Community Health. 2018 Mar;72(3):208-15. doi: 10.1136/jech-2017-20975
Khan AM, Urquia M, Kornas k, Henry D, Cheng SY, Bornbaum C, Rosella LC. Socioeconomic gradients in all-cause, premature and avoidable mortality among immigrants and long-term residents using linked death records in Ontario, Canada. J Epidemiol Community Health. 2017 Jul;71(7):625-32. doi: 10.1136/jech-2016-208525
Yosipovitch G, Reaney M, Eckert L, Nelson L, Clark M, Abbe A, Ardeleanu M, Radin A, Gadkari A. Validation of the peak pruritus numerical rating scale: results from clinical studies of dupilumab in adults with moderate-to-severe atopic dermatitis. Poster presented at the Australasian College of Dermatologists 50th Annual Scientific Meeting; May 2017. Sydney, Australia. [abstract] Australas J Dermatol. 2017 May; 58(S1):106-7. Previously presented at the 2017 American Academy of Dermatology Annual Meeting. doi: 10.1111/ajd.21_12652
Spelman LJ, Lebwohl M, Mordin M, Mallya UG, Gnanasakthy A, Fox T. Secukinumab treatment provides fast relief from patient-reported psoriasis burden. Poster presented at the 48th Australasian College of Dermatologists Annual Scientific Meeting; May 2015. Adelaide, Australia. [abstract] Australas J Dermatol. 2015 May; 56(Suppl 2):73.
Foley P, Sherif B, Mallya UG, Fox T, Gottlieb AB. Secukinumab treatment sustains patient-reported outcome benefits through 1 year. Poster presented at the 48th Australasian College of Dermatologists Annual Scientific Meeting; May 2015. Adelaide, Australia. [abstract] Australas J Dermatol. 2015 May; 56(Suppl 2):56.
Sinclair R, McLeod L, Mallya UG, Fox T, Strober B. Psoriasis patients with PASI90 response achieve greater health-related quality of life improvements than those with PASI75 response. Poster presented at the 48th Australasian College of Dermatologists Annual Scientific Meeting; May 2015. Adelaide, Australia. [abstract] Australas J Dermatol. 2015 May; 56(S2):68.
Hartley L, Girling A, Bowater R, Lilford R. A multistudy analysis investigating systematic differences in cardiovascular trial results between Europe and Asia. J Epidemiol Community Health. 2015 Apr;69(4):397-404. doi: 10.1136/jech-2013-203646
Hartley L, Flowers N, Holmes J, Clarke A, Stranges S, Hooper L. Green and black tea for the primary prevention of cardiovascular disease (CVD): a cochrane systematic review. Poster presented at the Society for Social Medicine conference at the Brighton and Sussex Medical School; September 2013. Brighton, United Kingdom. [abstract] J Epidemiol Community Health. 2013 Sep; 67(Suppl 1):A52-3. doi: 10.1136/jech-2013-203126.109
Vrijheid M, Martinez D, Aguilera I, Ballester F, Basterrechea M, Esplugues A, Guxens M, Larranaga M, Lertxundi A, Mendez M, Murcia M, Marina LS, Villanueva CM, Sunyer J. Socioeconomic status and exposure to multiple environmental pollutants during pregnancy: evidence for environmental inequity? J Epidemiol Community Health. 2012 Feb;66(2):106-13. doi: 10.1136/jech.2010.117408
Mendez MA, Plana E, Guxens M, Foradada Morillo CM, Albareda RM, Garcia-Esteban R. Seafood consumption in pregnancy and infant size at birth: results from a prospective Spanish cohort. J Epidemiol Community Health. 2010 Mar;64(3):216-22.
Watson V, Ryan M. Exploring preference anomalies in double bounded contingent valuation. J Health Econ. 2007 May 1;26(3):463-82. doi: 10.1016/j.jhealeco.2006.10.009
Loughlin JE, Rothman KJ, Dreyer NA. Lymphatic and haematopoietic cancer mortality in a population attending school adjacent to styrene-butadiene facilities, 1963-1993. J Epidemiol Community Health. 1999 Jan 1;53(5):283-7.
Poole C, Rothman KJ. Our conscientious objection to the epidemiology wars. J Epidemiol Community Health. 1998 Oct 1;52(10):613-4.